Propranolol for Treatment of Infantile Hemangioma: Efficacy and Effect on Pediatric Growth and Development

Table 1

Patient characteristics.

Gender
	Male	48
	Female	137
Birth history
Premature		45
Twin or triplet		14
NICU admission		32
	Median NICU length of stay (days)	12
	Average NICU length of stay (days)	21
Location of IH
	Head and neck	130
	Trunk	8
	Extremity	15
	Multifocal	31
	Unknown	1
Comorbidities that may affect growth or development
	Yes	43
	No	142
	Cardiac abnormalities	16
	Laryngomalacia	5
	Non-hemangioma surgery	23
Gestational history (mother)
	Preeclampsia	23
	Gestational diabetes	11
	Placental abnormalities	12
	First trimester bleeding	15
	Trauma	23
	Hypertension	23
	Tobacco or alcohol	8
	Amniocentesis	3
	Chorionic villus sampling	0
Other medications
	None	53
	Antacid (PPI or H2 blocker)	61
	Systemic steroid	5
	Other	59